Citations

Clear

50 citation(s) found for "Howard, Matthew".

Incidental EBV-positivity in paediatric post-transplant specimens demonstrates the need for stringent criteria for diagnosing post-transplant lymphoproliferative disorders
King, Rebecca L. , Paessler, Michele, Howard, Matthew T., Wertheim, Gerald

Mayo Clinic

Journal of Clinical Pathology | November 16, 2016 | Volume: 70 | Issue: 3 | Pages: 270-273

10.1136/jclinpath-2016-203924 | PMID 27852687 Get It

Aims To examine the need for minimal diagnostic criteria for post-transplant lymphoproliferative disorders (PTLD) in children, we sought to determine the rate of incidental Epstein-Barr virus (EBV)-positivity in tissues from organ transplant recipients (OTR). Methods EBV in situ hybridisation (ISH) was done retrospectively on tissue from 34 paediatric autopsies of OTR and paediatric tonsillectomy specimens from non-OTR (96) and OTR (6). Patients with a history of PTLD were excluded from both data sets. Results EBV-positivity was found incidentally in 2/34 autopsy cases (5.9%). Median time from transplant to death for all patients was 12.8 months (range 0.1–153 months). Median time between transplant and death in EBV-positive cases was 34 months. EBV was positive in 26/102 tonsils (25%). Among tonsils from OTR, 4/6 (67%) were EBV-positive. Conclusions These findings reinforce the need for strict morphological and clinical criteria, other than EBV-positivity, when diagnosing PTLD in the paediatric population.
Lymphocytic variant of hypereosinophilic syndrome mimicking peripheral T-cell lymphoma in a young woman
King, Rebecca L. , Howard, Matthew T.

Mayo Clinic

Blood | January 15, 2016 | Volume: 127 | Issue: 2 | Pages: 268-268

10.1182/blood-2015-10-674945 | PMID 28837310 Get It

Morphologically Occult Systemic Mastocytosis in Bone Marrow
Reichard, Kaaren K. , Chen, Dong , Pardanani, Animesh , McClure, Rebecca F., Howard, Matthew T., Kurtin, Paul J. , Wood, Adam J. , Ketterling, Rhett P. , King, Rebecca L. , He, Rong, Morice, William G. , Hanson, Curtis A. , Morice, William George , Chen, Dong , Ketterling, Rhett P

Mayo Clinic

American Journal of Clinical Pathology | August 14, 2015 | Volume: 144 | Issue: 3 | Pages: 493-502

10.1309/ajcpsgq71gjqqacl | PMID 26276780 Get It

Conventional Karyotyping and Fluorescence In Situ Hybridization
He, Rong , Wiktor, Anne E., Hanson, Curtis A. , Ketterling, Rhett P. , Kurtin, Paul J. , Dyke, Daniel L. Van , Litzow, Mark R. , Howard, Matthew H., Reichard, Kaaren K. , Ketterling, Rhett P

Mayo Clinic

American Journal of Clinical Pathology | May 13, 2015 | Volume: 143 | Issue: 6 | Pages: 873-878

10.1309/ajcpp6lvmqg4lnck | PMID 25972330 Get It

Immunophenotypic features by multiparameter flow cytometry can help distinguish low grade B‐cell lymphomas with plasmacytic differentiation from plasma cell proliferative disorders with an unrelated clonal B‐cell process
Rosado, Flavia, Morice, William G. , He, Rong , Howard, Matthew T., Timm, Michael, McPhail, Ellen D. , Rosado, Flavia G, Morice, William George , McPhail, Ellen Darcy

Mayo Clinic

British Journal of Haematology | February 2, 2015 | Volume: 169 | Issue: 3 | Pages: 368-376

10.1111/bjh.13303 | PMID 25644063 Get It

SummaryHighly sensitive flow cytometry studies may incidentally identify B cell clones when used to assess plasma cell clonality in bone marrows. Clinical history, which can help differentiate related clones (low grade B cell lymphoma with plasmacytic differentiation/LBCL‐PD) from unrelated ones (plasma cell proliferative disorder (PCPD) with an unrelated B cell clone), is often unavailable in referred specimens. We sought to identify morphologic or phenotypic features that would help predict the significance of these clones in the absence of history. We included only cases with identical light chain B and plasma cell clones, as determined by 6‐color flow cytometry with additional DNA ploidy analysis, in which the relationship between clones could be established by review of medical records. There were 26 cases; 18 were related (14 were Waldenstrom macroglobulinemia) and eight were unrelated (seven multiple myeloma). Features seen exclusively in LBCL‐PD include CD19+/CD45+ clonal plasma cell phenotype (66·7%, P = 0·0022) and morphologic features such as paratrabecular bone marrow involvement, increased mast cells, and plasma cells surrounding B‐cell nodules. Aneuploidy was identified exclusively in PCPD cases (75%, P = 0·000028). We conclude that CD19+/CD45+ clonal plasma cell phenotype and aneuploidy are useful in distinguishing related clones (LBCL‐PD) from unrelated clones (PCPD).
Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations
Mir, Muhammad A. , Kochuparambil, Samith T. , Abraham, Roshini S. , Rodriguez, Vilmarie , Howard, Matthew H., Jackson, Amie E., Holland, Steven M. , Patnaik, Mrinal M. , Hsu, Amy P.

Mayo Clinic

Cancer Medicine | January 26, 2015 | Volume: 4 | Issue: 4 | Pages: 490-499

10.1002/cam4.384 | PMID 25619630 Get It

AbstractGuanine‐adenine‐thymine‐adenine 2 (GATA2) mutated disorders include the recently described MonoMAC syndrome (Monocytopenia and Mycobacterium avium complex infections), DCML (dendritic cell, monocyte, and lymphocyte deficiency), familial MDS/AML (myelodysplastic syndrome/acute myeloid leukemia) (myeloid neoplasms), congenital neutropenia, congenital lymphedema (Emberger's syndrome), sensorineural deafness, viral warts, and a spectrum of aggressive infections seen across all age groups. While considerable efforts have been made to identify the mutations that characterize this disorder, pathogenesis remains a work in progress with less than 100 patients described in current literature. Varying clinical presentations offer diagnostic challenges. Allogeneic stem cell transplant remains the treatment of choice. Morbidity, mortality, and social costs due to the familial nature of the disease are considerable. We describe our experience with the disorder in three affected families and a comprehensive review of current literature.
Loss of Blast Heterogeneity in Myelodysplastic Syndrome and Other Chronic Myeloid Neoplasms
Jevremović, Dragan , Timm, Michael, Reichard, Kaaren K. , Morice, William G. , Hanson, Curtis A. , Viswanatha, David S., Howard, Matthew T., Nguyen, Phuong L., Timm, Michael M, Morice, William George , Jevremovic, Dragan

Mayo Clinic

American Journal of Clinical Pathology | August 14, 2014 | Volume: 142 | Issue: 3 | Pages: 292-298

10.1309/ajcp73qsllydegxk | PMID 25125617 Get It

Abstract Objectives: Flow cytometry immunophenotyping has been suggested as an adjunctive technique in the evaluation of myeloid malignancies, especially in the myelodysplastic syndromes. However, its use has been limited due to complexity and cost restraints. The goal of this study is to attempt a simpler approach to flow cytometry immunophenotyping in myeloid neoplasms. Methods: We analyzed bone marrow specimens of 45 selected patients and an additional 99 consecutive random patients using a limited antibody panel. Results: Normal CD34-positive blasts show a characteristic pattern of CD13/HLA-DR expression, with three readily identifiable subpopulations. In contrast, myeloid neoplasms frequently show loss of this heterogeneity. Conclusions: Analysis of a limited antibody panel with a focus on CD13/HLA-DR expression provides relatively high specificity and sensitivity for the detection of myeloid neoplasms.
Epstein-Barr Virus Infection in an Elderly Nonimmunocompromised Adult Successfully Treated with Rituximab
Smeltzer, Jacob P., Howard, Matthew T., Gonsalves, Wilson I. , Witzig, Thomas E.

Mayo Clinic

Case Reports in Hematology | February 10, 2014 | Volume: 2014 | Issue: No issue available | Pages: 1-4

10.1155/2014/641483 | PMID 24660077 Get It

Epstein-Barr virus (EBV) is a ubiquitous virus that commonly affects children and adolescents. In addition to causing a viral illness, it is also associated with various malignancies in particular B cell lymphomas and lymphoproliferative disorders. Differentiating between the two processes can be a diagnostic challenge. Here, we present a case of an atypical EBV infection in an elderly patient with severe systemic symptoms, multiorgan involvement, lymphadenopathy, and negative EBV serology. Excisional lymph node biopsy demonstrated features of a lymphoproliferative process involving EBV. Despite supportive care, she experienced continued clinical deterioration and was successfully treated with rituximab. This case illustrates the diagnostic challenges of these cases particularly in the elderly who may have age related immunosenescence, the utility of EBV PCR testing, and the clinical efficacy of rituximab in clearing the infected cells.
IgM Multiple Myeloma
King, Rebecca L. , Howard, Matthew T., Hodnefield, Janice M., Morice, William G. , Morice, William George

Mayo Clinic

American Journal of Clinical Pathology | September 17, 2013 | Volume: 140 | Issue: 4 | Pages: 519-524

10.1309/ajcp0n7ielyunjgz | PMID 24045549 Get It

Effect of Nitrous Oxide Use on Long-term Neurologic and Neuropsychological Outcome in Patients Who Received Temporary Proximal Artery Occlusion during Cerebral Aneurysm Clipping Surgery
Pasternak, Jeffrey J., McGregor, Diana G., Lanier, William L. , Schroeder, Darrell R. , Rusy, Deborah A. , Hindman, Bradley J. , Clarke, William R., Torner, James C., Todd, Michael M. , Hogan, Kirk J. , Tymianski, Michael , Durieux, Marcel E. , Torner, James C. , Hitchon, Patrick W. , Olivi, Alessandro , Giordani, Bruno , Greif, Robert , Davis, Gavin A , Howard, Matthew A. , Myles, Paul S. , Davis, Gavin A. , Schroeder, Darrell , Howard, Matthew A

Mayo Clinic

Anesthesiology | February 20, 2009 | Volume: 110 | Issue: 3 | Pages: 563-573

10.1097/aln.0b013e318197ff81 | PMID 19212259 Get It

Background The authors explored the relationship between nitrous oxide use and neurologic and neuropsychological outcome in a population of patients likely to experience intraoperative cerebral ischemia: those who had temporary cerebral arterial occlusion during aneurysm clipping surgery. Methods A post hoc analysis of a subset of the data from the Intraoperative Hypothermia for Aneurysm Surgery Trial was conducted. Only subjects who had temporary arterial occlusion during surgery were included in the analysis. Metrics of short-term and long-term (i.e., 3 months after surgery) outcome were evaluated via both univariate and multivariate logistic regression analysis. An odds ratio (OR) greater than 1.0 denotes a worse outcome in patients receiving nitrous oxide. Results The authors evaluated 441 patients, of which 199 received nitrous oxide. Patients receiving nitrous oxide had a greater risk of delayed ischemic neurologic deficits (i.e., the clinical manifestation of vasospasm) (OR, 1.78, 95% confidence interval [CI], 1.08-2.95; P = 0.025). However, at 3 months after surgery, there was no difference in any metric of gross neurologic outcome: Glasgow Outcome Score (OR, 0.67; CI, 0.44-1.03; P = 0.065), Rankin Score (OR, 0.74; CI, 0.47-1.16; P = 0.192), National Institutes of Health Stroke Scale (OR, 1.02; CI, 0.66-1.56; P = 0.937), or Barthel Index (OR, 0.69; CI, 0.38-1.25; P = 0.22). The risk of impairment on at least one test of neuropsychological function was reduced in those who received nitrous oxide (OR, 0.56; CI, 0.36-0.89; P = 0.013). Conclusion In this patient population, use of nitrous oxide was associated with an increased risk for the development of delayed ischemic neurologic deficits; however, there was no evidence of detriment to long-term gross neurologic or neuropsychological outcome.